Equities

Virpax Pharmaceuticals Inc

VRPX:NAQ

Virpax Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.7064
  • Today's Change-0.034 / -4.54%
  • Shares traded42.51k
  • 1 Year change-91.23%
  • Beta1.1257
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Virpax Pharmaceuticals Inc fell by 9.85m. In addition, the company used more cash to support its operations than it earned, posting a cash flow loss of 9.85m. In addition the company used on investing activities and also paid in financing cash flows.
Cash flow per share-9.23
Price/Cash flow per share--
Book value per share-0.9847
Tangible book value per share-0.9847
More ▼

Balance sheet in USDView more

Virpax Pharmaceuticals Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio0.4811
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.